Premedication with controlled-release oxycodone does not improve management of postoperative pain after day-case gynaecological laparoscopic surgery

British Journal of Anaesthesia

Volumn 98, Issue 2, 2007, Pages 255-260

  Jokela, Ritva ^a   Ahonen, J ^a   Valjus, M ^a   Seppala T ^b   Korttila, K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Analgesia, postoperative; Oxycodone, controlled release; Oxycodone, normal release; Plasma concentration; Premedication; Surgery, day case

Indexed keywords

DEXAMETHASONE; DIAZEPAM; DROPERIDOL; FENTANYL; GLYCOPYRRONIUM BROMIDE; IBUPROFEN; NEOSTIGMINE; ONDANSETRON; OXYCODONE; PLACEBO; PROPOFOL; REMIFENTANIL; ROCURONIUM; NARCOTIC ANALGESIC AGENT;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG BLOOD LEVEL; FEMALE; GYNECOLOGIC SURGERY; HEADACHE; HOSPITAL DISCHARGE; HUMAN; INFORMED CONSENT; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MICTURITION DISORDER; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PREMEDICATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; STATISTICAL ANALYSIS; VISUAL ANALOG SCALE; AMBULATORY SURGERY; BLOOD; CHEMICALLY INDUCED DISORDER; DELAYED RELEASE FORMULATION; LAPAROSCOPY; METHODOLOGY; MIDDLE AGED;

ADULT; AMBULATORY SURGICAL PROCEDURES; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LAPAROSCOPY; MIDDLE AGED; OXYCODONE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE NAUSEA AND VOMITING; PREMEDICATION;

EID: 33847728579     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael342     Document Type: Article

References (23)

1. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003; 97: 534-40
2. Mattila K, Toivonen J, Janhunen L, Rosenberg PH, Hynynen M. Post-discharge symptoms after ambulatory surgery: First-week incidence, intensity, and risk factors. Anesth Analg 2005; 101: 1643-50
3. Gold BS, Kitz DS, Lecky JH, Neuhaus JM. Unanticipated admission to the hospital following ambulatory surgery. JAMA 1989; 262: 3008-10
4. Wu CL, Berenholtz SM, Pronovost PJ, Fleisher LA. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology 2002; 96: 994-1003
5. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78: 606-17
6. Kehlet H, Holte K. Effect of analgesia on surgical outcome. Br J Anaesth 2001; 87: 62-72
7. Kalso E. Oxycodone. J Pain Symptom Manage 2005; 29: S47-56
8. Davis MP, Varga J, Dickerson D, Walsh D, Legrand SB, Lagman R. Normal-release and controlled-release oxycodone: Pharmacokinetics, pharmacodynamics, and controversy. Support Care Cancer 2003; 11 84-92
9. Curtis GB, Johnson GH, Clark P, et al. Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol 1999; 55: 425-9
10. Reuben S, Connelly NR, Maciolek H. Postoperative analgesia with controlled-release oxycodone for outpatient anterior cruciate ligament surgery. Anesth Analg 1999; 88: 1286-91.
11. Reuben SS, Steinberg RB, Maciolek H, Joshi W. Preoperative administration of controlled-release oxycodone for the management of pain after ambulatory laparoscopic tubal ligation surgery. J Clin Anesth 2002; 14: 223-7
12. Romundstad L, Breivik H, Roald H, et al. Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: A single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo. Anesth Analg 2006; 102 418-25
13. Pöyhiä R, Seppälä T, Olkkola KT, Kalso E. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol 1992; 33: 617-21
14. Lalovic B, Kharasch E, Hoffer C, Risler L, Liu-Chen LY, Shen DD. Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites. Clin Pharmacol Ther 2006; 79: 461-79
15. Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheim PD. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996; 59: 52-61
16. Benziger DP, Miotto J, Grandy RP, Thomas GB, Swanton RE, Fitzmartin RD. A pharmacokinetic/pharmacodynamic study of controlled-release oxycodone. J Pain Symptom Manage 1997; 13: 75-82
17. Silvasti M, Rosenberg PH, Seppälä T, Svartling N, Pitkänen M. Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Acta Anaesthesiol Scand 1998; 42: 576-80
18. Heiskanen T, Olkkola K, Kalso E. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacol Ther 1998; 64: 603-11
19. Mandema JW, Kaiko RF, Oshlack B, Reder RF, Stanski DR. Characterization and validation of a pharmacokinetic model for controlled-release oxycodone. Br J Clin Pharmacol 1996; 42: 747-56
20. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial to study six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-51
21. Rawal N, Hylander J, Nydahl PA, Olofsson I, Gupta A. Survey of postoperative analgesia following ambulatory surgery. Acta Anaesth Scand 1997; 41: 1017-22
22. Beauregard L, Pomp A, Chonière M. Severity and impact of pain after day-surgery. Can J Anaesth 1998; 45: 304-11
23. Møiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief. Anesthesiology 2002; 96: 725-41